(Q42990781)

12 November 2017

Comparative analysis of triplex nucleic acid test assays in United States blood donors (English)

1 reference

12 November 2017

United States of America

0 references

1

Susan L Stramer

1 reference

12 November 2017

David E Krysztof

2

1 reference

12 November 2017

Jaye P Brodsky

3

1 reference

12 November 2017

Tracy A Fickett

4

1 reference

12 November 2017

Benjamin Reynolds

5

1 reference

12 November 2017

Roger Y Dodd

6

1 reference

12 November 2017

Steven H Kleinman

7

1 reference

12 November 2017

3 April 2013

1 reference

12 November 2017

1 reference

12 November 2017

53

1 reference

12 November 2017

10 Pt 2

1 reference

12 November 2017

2525-2537

1 reference

International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009.

12 November 2017

1 reference

Sensitivity of two hepatitis B virus, hepatitis C virus (HCV), and human immunodeficiency virus (HIV) nucleic acid test systems relative to hepatitis B surface antigen, anti-HCV, anti-HIV, and p24/anti-HIV combination assays in seroconversion panels

21 January 2018

1 reference

Comparison of two automated nucleic acid testing systems for simultaneous detection of human immunodeficiency virus and hepatitis C virus RNA and hepatitis B virus DNA.

21 January 2018

1 reference

One-year experience of nucleic acid technology testing for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus in Thai blood donations

21 January 2018

1 reference

Occult hepatitis B virus infection in Thai blood donors

21 January 2018

1 reference

Sensitivity comparison of two Food and Drug Administration-licensed, triplex nucleic acid test automated assays for hepatitis B virus DNA detection and associated projections of United States yield

21 January 2018

1 reference

Nucleic acid testing to detect HBV infection in blood donors.

21 January 2018

1 reference

Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing

21 January 2018

1 reference

Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value?

21 January 2018

1 reference

Current incidence and residual risk of hepatitis B infection among blood donors in the United States.

21 January 2018

1 reference

Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen

21 January 2018

1 reference

Note on the sampling error of the difference between correlated proportions or percentages

21 January 2018

1 reference

Analysis of clustered matched-pair data

21 January 2018

1 reference

A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors

21 January 2018

1 reference

Relative sensitivities of licensed nucleic acid amplification tests for detection of viremia in early human immunodeficiency virus and hepatitis C virus infection

21 January 2018

1 reference

Comparison of the analytical and operational performance of two viral nucleic acid test blood screening systems: Procleix Tigris and cobas s 201.

21 January 2018

1 reference

Occult hepatitis B virus infection: implications in transfusion

21 January 2018

1 reference

Statements from the Taormina expert meeting on occult hepatitis B virus infection

21 January 2018

1 reference

Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy

21 January 2018

1 reference

Evidence for persistent low-level viremia in individuals who control human immunodeficiency virus in the absence of antiretroviral therapy

21 January 2018

1 reference

Hepatitis B virus transmission by blood transfusion during 4 years of individual-donation nucleic acid testing in South Africa: estimated and observed window period risk.

21 January 2018

1 reference

Hepatitis B virus infection and transfusion medicine: science and the occult

21 January 2018

1 reference

Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa

21 January 2018

1 reference

Dynamics of viremia in early hepatitis C virus infection

21 January 2018

1 reference

Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population

21 January 2018

1 reference

Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing

21 January 2018

1 reference

Integration of nucleic acid amplification test results into hepatitis C virus supplemental serologic testing algorithms: implications for donor counseling and revision of existing algorithms

21 January 2018

1 reference

The natural history of hepatitis C virus infection: host, viral, and environmental factors

21 January 2018

1 reference

Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: A National Heart, Lung, and Blood Institute collaborative study

21 January 2018

1 reference

Clearance of hepatitis C virus after newly acquired infection in injection drug users

21 January 2018

1 reference

Diagnosis, management, and treatment of hepatitis C

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/TRF.12178

1 reference

12 November 2017

1 reference